Cargando…
Vaginal and oral use of probiotics as adjunctive therapy to fluconazole in patients with vulvovaginal candidiasis: A clinical trial on Iranian women
BACKGROUND AND PURPOSE: Vulvovaginal candidiasis is considered the second most prevalent gynecologic infection among women and one of the main reasons for referring to a gynecologist. During recent decades, probiotic usage has been defined as one of the therapeutic regimens for vaginal candidiasis m...
Autores principales: | Vahedpoor, Zahra, Abastabar, Mahdi, Sehat, Mojtaba, Talebian, Parisa, Felfelian Fini, Tayebeh, Dastanpour, Zahra, Haghani, Iman, Chelongarian, Ramtin, Nazeri, Mehdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iranian Society of Medical Mycology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006731/ https://www.ncbi.nlm.nih.gov/pubmed/35528620 http://dx.doi.org/10.18502/cmm.7.3.7803 |
Ejemplares similares
-
Comparison between Fluconazole with Oral Protexin Combination and Fluconazole in the Treatment of Vulvovaginal Candidiasis
por: Nouraei, S., et al.
Publicado: (2012) -
Species distribution and susceptibility profiles of Candida species isolated from vulvovaginal candidiasis, emergence of C. lusitaniae
por: Hashemi, Seyed Ebrahim, et al.
Publicado: (2019) -
Comparing the Effect of Probiotic and Fluconazole on Treatment and Recurrence of Vulvovaginal Candidiasis: a Triple-Blinded Randomized Controlled Trial
por: Mollazadeh-Narestan, Zahra, et al.
Publicado: (2022) -
Corrigendum to “Comparison between Fluconazole with Oral Protexin Combination and Fluconazole in the Treatment of Vulvovaginal Candidiasis”
por: Nouraei, S., et al.
Publicado: (2017) -
Phase 2 Randomized Study of Oral Ibrexafungerp Versus Fluconazole in Vulvovaginal Candidiasis
por: Nyirjesy, Paul, et al.
Publicado: (2021)